CA2100251A1 - Regulation of nucleic acid translation - Google Patents

Regulation of nucleic acid translation

Info

Publication number
CA2100251A1
CA2100251A1 CA 2100251 CA2100251A CA2100251A1 CA 2100251 A1 CA2100251 A1 CA 2100251A1 CA 2100251 CA2100251 CA 2100251 CA 2100251 A CA2100251 A CA 2100251A CA 2100251 A1 CA2100251 A1 CA 2100251A1
Authority
CA
Canada
Prior art keywords
region
rna
responsive rna
responsive
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2100251
Other languages
English (en)
French (fr)
Inventor
Robert L. Lechner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Biochemical Corp
Original Assignee
United States Biochemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States Biochemical Corp filed Critical United States Biochemical Corp
Publication of CA2100251A1 publication Critical patent/CA2100251A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA 2100251 1991-01-25 1992-01-24 Regulation of nucleic acid translation Abandoned CA2100251A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64610991A 1991-01-25 1991-01-25
US646,109 1991-01-25

Publications (1)

Publication Number Publication Date
CA2100251A1 true CA2100251A1 (en) 1992-07-26

Family

ID=24591791

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2100251 Abandoned CA2100251A1 (en) 1991-01-25 1992-01-24 Regulation of nucleic acid translation

Country Status (7)

Country Link
EP (1) EP0568641A4 (ja)
JP (1) JPH06505161A (ja)
AU (1) AU1341092A (ja)
CA (1) CA2100251A1 (ja)
IE (1) IE920229A1 (ja)
PT (1) PT100052A (ja)
WO (1) WO1992013070A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4234293A (en) * 1992-05-14 1993-12-13 Ribozyme Pharmaceuticals, Inc. Virus resistant plants containing inducible cytotoxic mrnas
EP0707638A4 (en) * 1992-12-04 1998-05-20 Innovir Lab Inc REGULABLE NUCLEIC ACID FOR THERAPEUTIC USE AND METHODS OF USE THEREOF
AU8088794A (en) * 1993-10-25 1995-05-22 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Plasmids for efficient expression of synthetic genes in (e. coli)
US5631148A (en) * 1994-04-22 1997-05-20 Chiron Corporation Ribozymes with product ejection by strand displacement
BR9810460A (pt) 1997-06-25 2001-11-27 Charles Allen Black Jr Cassete de expressão mascarado e métodos paracontrolar a expressão e produzir uma proteìnade interesse
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
CZ295108B6 (cs) 1998-03-20 2005-05-18 Benitec Australia Ltd Syntetický gen obsahující dispergovanou nebo cizorodou deoxyribonukleovou molekulu a genový konstrukt obsahující tento syntetický gen
US8598332B1 (en) 1998-04-08 2013-12-03 Bayer Cropscience N.V. Methods and means for obtaining modified phenotypes
ATE507299T1 (de) 1998-04-08 2011-05-15 Commw Scient Ind Res Org Verfahren und mittel zum erhalt von veränderten phänotypen
US20040214330A1 (en) 1999-04-07 2004-10-28 Waterhouse Peter Michael Methods and means for obtaining modified phenotypes
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
EP3218483A4 (en) 2014-11-14 2018-07-18 Ionis Pharmaceuticals, Inc. Compounds and methods for the modulation of proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820639A (en) * 1985-12-04 1989-04-11 Massachusetts Institute Of Technology Process for enhancing translational efficiency of eukaryotic mRNA
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
WO1989000604A1 (en) * 1987-07-13 1989-01-26 Interferon Sciences, Inc. Method for improving translation efficiency

Also Published As

Publication number Publication date
EP0568641A1 (en) 1993-11-10
PT100052A (pt) 1993-03-31
AU1341092A (en) 1992-08-27
JPH06505161A (ja) 1994-06-16
WO1992013070A1 (en) 1992-08-06
IE920229A1 (en) 1992-07-29
EP0568641A4 (en) 1994-09-14

Similar Documents

Publication Publication Date Title
EP0291533B1 (en) Rna ribozyme restriction endoribonucleases and methods
US6146886A (en) RNA polymerase III-based expression of therapeutic RNAs
US20180179526A1 (en) Method and Medicament For Inhibiting The Expression of A Given Gene
US5902880A (en) RNA polymerase III-based expression of therapeutic RNAs
Woodson et al. Reverse self-splicing of the Tetrahymena group I intron: implication for the directionality of splicing and for intron transposition
US6265167B1 (en) Targeted RNA degradation using nuclear ribozyme RNA
Pintel et al. The genome of minute virus of mice, an autonomous parvovirus, encodes two overlapping transcription units
EP0748383B1 (en) Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
US5624824A (en) Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
Cormack et al. Structural requirements for the processing of Escherichia coli 5 S ribosomal RNA by RNase E in vitro
US5646031A (en) SArMV and sCYMVI hairpin ribozymes
CA2100251A1 (en) Regulation of nucleic acid translation
Doudna et al. Miniribozymes, small derivatives of the sunY intron, are catalytically active
Decatur et al. Two group I ribozymes with different functions in a nuclear rDNA intron.
Adema et al. Uridine branch acceptor is a cis-acting element involved in regulation of the alternative processing of calcitonin/CGRP-I pre-mRNA
van Gelder et al. Common structural features of the Ro RNP associated hY1 and hY5 RNAs
Choffat et al. Pseudouridine Modification in the tRNATyr Anticodon is Dependent on the Presence, but Independent of the Size and Sequence, of the Intron in Eucaryotic tRNA (Tyr) Genes
AU4234293A (en) Virus resistant plants containing inducible cytotoxic mrnas
Domenjoud et al. Identification of a specific exon sequence that is a major determinant in the selection between a natural and a cryptic 5′ splice site
Gouilloud et al. A dispersed tyrosine tRNA gene from Xenopus laevis with high transcriptional activity in vitro.
Woisetschläger et al. The kdsA gene coding for 3-deoxy-D-manno-octulosonic acid 8-phosphate synthetase is part of an operon in Escherichia coli
EP0400093A1 (en) Gene synthesis
Grivell Transposition: Mobile introns get into line
Hur In vitro splicing activities of the Aspergillus nidulans mitochondrial group I introns

Legal Events

Date Code Title Description
FZDE Dead